Mor Y, Shenfeld O, Leibovich I, Raviv G, Nativ O, Goldwasser B
Department of Urology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Isr J Med Sci. 1995 Feb-Mar;31(2-3):129-32.
In recent years radical retropubic prostatectomy is used with increasing frequency to treat localized cancer of the prostate. We report our experience with 100 consecutive cases of prostate cancer that underwent this operation; there were no cases of mortality and a 7% rate of postoperative complications. More than 90% of the patients are socially continent postoperatively and 20% have retained sexual potency. Ninety-four percent of the patients are free of disease (mean follow-up period 18 months). In our opinion, such results support the use of radical retropubic prostatectomy for the treatment of localized prostate cancer in well-selected patients.
近年来，耻骨后根治性前列腺切除术治疗局限性前列腺癌的应用频率越来越高。我们报告了连续100例接受该手术的前列腺癌患者的经验；无死亡病例，术后并发症发生率为7%。超过90%的患者术后社交控尿，20%保留了性功能。94%的患者无疾病复发（平均随访期18个月）。我们认为，这些结果支持在精心挑选的患者中使用耻骨后根治性前列腺切除术治疗局限性前列腺癌。
